Core Viewpoint - The article emphasizes the importance of "five-dimensional positive growth" for companies, which includes continuous growth in total assets, operating income, net profit attributable to shareholders, R&D investment, and employee compensation from 2022 to 2024, as a measure of a company's internal motivation and sustainable development capability [2][3]. Summary by Sections Five-Dimensional Positive Growth - Companies with long-term competitiveness maintain steady growth not only in asset scale and revenue but also in innovation investment and human capital [3]. - A total of 156 companies in the A-share market meet the criteria of achieving three consecutive years of growth in the five key indicators, indicating a focus on solid asset foundations and strategic investments in R&D and employee compensation [3][4]. Industry Distribution - The 156 companies are concentrated in sectors such as machinery, electronics, power equipment, pharmaceuticals, and automobiles, highlighting the transformation and upgrading of China's manufacturing industry through technological accumulation and talent investment [4][6]. - The automotive sector leads with 30 companies, followed by power equipment (22), machinery (20), electronics (14), and pharmaceuticals (13), collectively accounting for over 63% of the group [6]. Key Industry Analysis - **Automotive**: The sector shows strong market vitality, particularly in new energy vehicles, with companies like BYD demonstrating significant growth through vertical supply chain integration and R&D investment [9]. - **Power Equipment**: Companies like Sungrow Power Supply benefit from global green energy demand, with continuous R&D ensuring technological leadership [12]. - **Machinery**: Companies such as Times Electric leverage their technological advantages to achieve growth in both domestic and international markets [13]. - **Electronics**: Firms like North Huachuang are capitalizing on domestic semiconductor expansion, with R&D driving rapid growth [15]. - **Pharmaceuticals**: Companies like Mindray Medical are expanding through continuous innovation in medical technology, supported by robust R&D investment [16]. Internal Logic of Growth - Achieving simultaneous growth in the five dimensions is challenging, with only 156 out of 5,383 A-share companies meeting the criteria by the end of 2024 [18]. - The interplay between R&D investment and human capital is crucial for maintaining competitive advantage in a rapidly evolving market [19][20]. Long-Termism and Employee Compensation - Employee compensation and R&D investment are identified as dual anchors of long-termism, with average employee compensation increasing by approximately 35% and R&D investment by about 42% from 2021 to 2024 among the 156 companies [25]. - This focus on human and innovation capital, despite potential short-term impacts on profit margins, enhances organizational stability and competitive barriers [25]. Conclusion - The article concludes that the concept of being a "respected" company should not solely rely on scale or profit but should also encompass the creation of economic value while promoting technological advancement, employee growth, and social welfare [26].

Core Insights - The evaluation criteria for companies in China are shifting from a focus on single profit metrics to a multidimensional assessment of capabilities, emphasizing long-term competitiveness through sustained growth in assets, revenue, net profit, R&D investment, and employee compensation [1][19] - A total of 156 companies in the A-share market have met the criteria of achieving positive growth across these five dimensions for three consecutive years, indicating a robust foundation for sustainable development [1][13] Industry Distribution - The 156 companies are primarily distributed across sectors such as machinery, electronics, power equipment, pharmaceuticals, and automotive, highlighting the transformation and upgrading of China's manufacturing industry through technological accumulation and talent investment [2][5] - The automotive sector leads with 30 companies, followed by power equipment (22), machinery (20), electronics (14), and pharmaceuticals (13), collectively accounting for over 63% of the total [3][5] Key Industries and Representative Companies - **Automotive (30 companies)**: This sector includes traditional vehicles, new energy vehicles, and smart solutions, showcasing China's leadership in the global automotive industry transformation [6] - BYD (002594.SZ) has demonstrated strong growth through vertical integration and significant R&D investment, establishing a robust competitive barrier [6] - Fuyao Glass (600660.SH) has capitalized on the trend of automotive intelligence and consumer upgrades, enhancing product value and driving revenue growth [7] - **Power Equipment (22 companies)**: This sector benefits from the dual carbon strategy, with growth driven by advancements in renewable energy technologies and smart grid construction [8] - Sungrow Power Supply (300274.SZ) has seen rapid growth due to its leadership in photovoltaic inverters and energy storage systems [8] - Guoxuan High-tech (002074.SZ) focuses on battery technology, leveraging continuous investment in R&D to build a competitive edge [8] - **Machinery (20 companies)**: This sector reflects the transformation of Chinese manufacturing, with companies benefiting from domestic industrial upgrades [9] - Times Electric (688187.SH) has sustained growth through its core competencies in rail transit equipment and expansion into new industries [9] - Tiandi Technology (600582.SH) leads in intelligent coal mining equipment, achieving steady growth through technological advancements [10] - **Electronics (14 companies)**: This sector has shown significant growth, driven by demand in semiconductors, high-end components, and consumer electronics [11] - Northern Huachuang (002371.SZ) has benefited from the expansion of domestic wafer fabrication, leading to rapid revenue growth [11] - Haiguang Information (688041.SH) has established a strong presence in the domestic CPU market, capitalizing on the demand for localized computing power [11] - **Pharmaceuticals (13 companies)**: This sector is driven by aging populations and increased health awareness, with companies focusing on R&D in innovative drugs and high-end medical devices [12] - Mindray Medical (300760.SZ) has built core competencies through continuous innovation in medical technology [12] - East China Pharmaceutical (000963.SZ) is expanding its growth through innovative drug development and aesthetic medicine [12] Five-Dimensional Growth Logic - Achieving positive growth across the five dimensions is a complex task, with only 156 out of 5,383 A-share companies meeting this standard, indicating a strong correlation between R&D investment and sustainable growth [13][18] - The combination of total assets, revenue, net profit, R&D investment, and employee compensation reflects a company's health and sustainability, with each dimension interlinked [14][15][16]